Assessment of Mandibular Posterior Available Space in Skeletal Class I and Class III Malocclusion Patients
Oral Sciences Reports · 07.08.2026 · 47 (3) · 400-408
DOI: 10.12982/osr.2026.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Sciences Reports, online erschienen am 07.08.2026. Verfasst von Kanticha Chailom und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
This study aimed to compare the mandibular posterior available space between patients with skeletal Class I and skeletal Class III malocclusion.
Methods
The retrospectively analyzed cone-beam computed tomography (CBCT) scans from 60 Thai orthodontic patients with normodivergent patterns. Patients were allocated to skeletal Class I or Class III; Class III severity was stratified by Wits appraisal. Mandibular posterior available space (MPAS) was measured on axial slice of CBCTs at the crown level and at root levels 3, 6 and 9 mm (RL3, RL6 and RL9) apical to the cementoenamel junction. Comparisons of the mandibular posterior available space between skeletal Class I and Class III groups were performed using the Mann-Whitney U test. The value of p
Zitieren
APA
Chailom, K., Sirabanchongkran, S., Tripuwabhrut, K., & Kuharattanachai, K. (2026). Assessment of Mandibular Posterior Available Space in Skeletal Class I and Class III Malocclusion Patients. Oral Sciences Reports, 47(3), 400-408. https://doi.org/10.12982/osr.2026.042
Vancouver
Chailom K, Sirabanchongkran S, Tripuwabhrut K, Kuharattanachai K. Assessment of Mandibular Posterior Available Space in Skeletal Class I and Class III Malocclusion Patients. Oral Sciences Reports. 2026;47(3):400-408. doi:10.12982/osr.2026.042
BibTeX
@article{Chailom2026,
author = {Chailom, Kanticha and Sirabanchongkran, Supassara and Tripuwabhrut, Kanich and Kuharattanachai, Kachaphol},
title = {Assessment of Mandibular Posterior Available Space in Skeletal Class I and Class III Malocclusion Patients},
journal = {Oral Sciences Reports},
year = {2026},
volume = {47},
number = {3},
pages = {400--408},
doi = {10.12982/osr.2026.042}
}
EUVIMED